Association of p53/p21 expression and cigarette smoking with tumor progression and poor prognosis in non-small cell lung cancer patients

By  

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2517-2526

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC)

By Monnet I.   Brienza S.   Hugret F.   Voisin S.   Gastiaburu J.   Saltiel J.C.   Soulie P.   Armand J.P.   Cvitkovic E.   de Cremoux H.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1124-1127

Elsevier

Access to resources Recommend Favorite

Polymorphisms in intron 1 of the EGFR gene in nonsmall cell lung cancer patients

By                              

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-01 ,pp. : 785-789

Spandidos Publications

Access to resources Recommend Favorite

p53-regulated GML gene expression in non-small cell lung cancer - a promising relationship to cisplatin chemosensitivity

By Higashiyama M.   Miyoshi Y.   Kodama K.   Yokouchi H.   Takami K.   Nishijima M.   Nakayama T.   Kobayashi H.   Minamigawa K.   Nakamura Y.  

European Journal of Cancer, Vol. 36, Iss. 4, 2000-03 ,pp. : 489-495

Elsevier

Access to resources Recommend Favorite

The expressions and clinical significance of P53, C-erbB-2 and VEGF in non-small cell lung cancer

By Gu Aiqin  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 78-80

Springer Publishing Company

Access to resources Recommend Favorite